MYCN and neuroblastoma: The International Neuroblastoma Risk Group (INRG) has developed a classification system for neuroblastoma risk stratification based on clinical criteria, including stage, histology, differentiation, ploidy, alterations at chromosome 11q, and amplification of MYCN [8].